The Cancer Biomarkers Research Group promotes research to identify, develop, and validate biological markers for early cancer detection and cancer risk assessment. Activities include development and validation of promising cancer biomarkers, collaborative databases and informatics systems, and new technologies or the refinement of existing technologies.
Read more About the Cancer Biomarkers Research Group.
Pancreatic Cancer Detection Consortium Steering Committee Meeting: A Tribute to Dr. Gloria Peterson
Date Posted: June 14, 2023
Speaker(s): Ann Oberg, Ph.D.; Suresh Chari, M.D.; Sudhir Srivastava, Ph.D., M.P.H.; Michael Goggins, M.D.; Lynn Matrisian, Ph.D., M.B.A.; Alison Klein, Ph.D., M.H.S.; Marian Pasca di Magliano, Ph.D.; Peter Allen, M.D.
Sponsor(s): NCI Division of Cancer Prevention, Cancer Biomarkers Research Group
This is an open workshop and free to attend. Registration is required.
News and Events
Executive Summary of the May 1-2, 2023 Precancer Atlas (PCA) Think Tank Meeting
Date Posted: September 5, 2023
Eliminating Underlying Liver Disease Remains Key Strategy for Liver Cancer Prevention
Date Posted: May 4, 2023
Engineering Synthetic Biomarkers for Early Detection of Cancers
Date Posted: February 9, 2022
Identifying New Biomarkers to Detect Lung Cancer Earlier
Date Posted: January 14, 2022
Could A Diabetes Diagnosis Help Detect Pancreatic Cancer Early?
Date Posted: July 7, 2021